StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)

Close on Nov 17, 2026Market cap $200.25MP/E –Yield –

Vogenx cash

Cash and short-term investments held at the end of each period.

Vogenx's cash was $193.02K at Jun 30, 2026. For fiscal 2025 it was $601.01K, down 37.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$601.01K-37.6%
FY2024Dec 31, 2024$962.92K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$193.02K–
Q4 FY2025Dec 31, 2025$601.01K–
Q2 FY2025Jun 30, 2025$390.28K–
Q4 FY2024Dec 31, 2024$962.92K–

More Vogenx figures

See a number that looks wrong?